CoreSite Realty Corp. COR 深 滬
已收盤 08-08 16:00:00 美东时间
285.13
+6.730
+2.42%
華盛通- 最 高285.99
- 今 開279.03
- 成交量 110.62万股
- 最 低 279.03
- 昨 收 278.40
- 總市值 553.15亿
- 52周最高 308.80
- 市盈率 靜 37.84
- 換手率 0.57%
- 52周最低 217.00
- 委 比 87.39%
- 總股本 1.94亿
- 歷史最高 308.80
- 量 比 0.71
- 振 幅 2.50%
- 歷史最低 -6.275
- 每 手 1
- 風險率 26.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多AVALON HOLDINGS CORPORATION ANNOUNCES SECOND QUARTER RESULTS
WARREN, Ohio, Aug. 8, 2025 /PRNewswire/ -- Avalon Holdings Corporation (NYSE Amex: AWX) today announced financial results for the second quarter of 2025. Net operating revenues in the second...
08-09 05:05
CORRECTION: Tucows Q2 Adj. EPS $(1.47) Up From $(1.63) YoY, Sales $98.463M Up From $89.423M YoY
Tucows (NASDAQ:TCX) reported quarterly losses of $(1.47) per share. This is a 9.82 percent increase over losses of $(1.63) per share from the same period last year. The company reported $98.463 million in sales this
08-08 06:27
CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings
<p> CorMedix announced the acquisition of Melinta Therapeutics for $300 million, expanding its product portfolio with seven innovative hospital-focused infectious disease products and a pipeline with growth potential. The deal is expected to be accretive to EPS in 2026, with annual synergies of ~$35-$45 million. Pro forma 2025 revenues are estimated at $305-$335 million. The transaction advances CorMedix's strategy to build a specialty pharmaceu...
08-07 11:00
CORRECTION: Gladstone Commercial Q2 Core FFO $0.35, Inline, Sales $39.533M Beat $38.318M Estimate
Gladstone Commercial (NASDAQ:GOOD) reported quarterly earnings of $0.35 per share which met the analyst consensus estimate. This is a 2.78 percent decrease over earnings of $0.36 per share from the same period last year.
08-07 06:19
AppLovin Q2 Earnings: Revenue Miss, EPS Beat, Shares Slide (CORRECTED)
AppLovin reports second-quarter revenue of $1.26 billion, missing analyst estimates of $1.31 billion, according to Benzinga Pro.
08-07 05:49
CORRECTION: AppLovin Sees Q3 Sales $1.320B-$1.340B vs $1.314B Est
Third Quarter 2025 Financial Guidance Summary:(In millions, except percentages)3Q25 Low HighRevenue$1,320 $1,340 Adjusted EBITDA$1,070 $1,090 Adjusted EBITDA
08-07 05:44
CORRECTION: Astronics Raises FY2025 Sales Guidance from $820.000M-$860.000M to $840.000M-$860.000M vs $844.813M Est
2025 OutlookAstronics is raising the lower end of its 2025 revenue guidance to approximately $840 million to $860 million, up from previous guidance of $820 million to $860 million. The midpoint of the revised range
08-07 04:45
Wall Street Recovers, Apple Rallies 6% On $100-Billion Gov Manufacturing Investment: What's Moving Markets Wednesday?
U.S. stocks rebounded sharply on Wednesday, fully erasing last Friday's losses, as upbeat corporate earnings and renewed investor optimism outweighed concerns over escalating trade tensions.
08-07 01:43
Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook
Cencora reports Q3 sales of $80.66 billion and EPS of $4.00, both above estimates, driven by GLP-1 and specialty drug demand in U.S. markets.
08-07 01:13
Cencora declares $0.55 dividend
Cencora (NYSE:COR) declares $0.55/share quarterly dividend, in line with previous. Forward yield 0.75% Payable Sept. 3; for shareholders of record Aug. 15; ex-div Aug. 15. See COR Dividend Scorecard, ...
08-06 20:54
